BCL2 and breast carcinoma: Three well‐developed bioinformatics algorithms (RNAhybrid 2.1, TargetScan, and PicTar) predicted that miR‐497 targets mTOR and Bcl‐2 (Fig. 3A), which had been reported as targets in ovarian and breast cancer cells 12, 18.